|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 128.55 EUR | +1.22% |
|
+2.55% | +4.85% |
| Feb. 13 | Health Care Up Amid Mixed Earnings - Health Care Roundup | DJ |
| Feb. 13 | Sanofi's new CEO needs to fix drug pipeline and navigate Trump | RE |
| Capitalization | 55.89B 66.04B 50.99B 48.75B 90.3B 5,990B 93.44B 594B 235B 2,890B 248B 243B 10,195B | P/E ratio 2025 * |
19.6x | P/E ratio 2026 * | 19.7x |
|---|---|---|---|---|---|
| Enterprise value | 63.95B 75.57B 58.34B 55.78B 103B 6,854B 107B 680B 269B 3,307B 283B 278B 11,665B | EV / Sales 2025 * |
3.02x | EV / Sales 2026 * | 2.91x |
| Free-Float |
29.72% | Yield 2025 * |
1.8% | Yield 2026 * | 1.88% |
Last Transcript: Merck KGaA
| 1 day | +1.22% | ||
| 1 week | +2.55% | ||
| Current month | +2.39% | ||
| 1 month | -1.12% | ||
| 3 months | +15.14% | ||
| 6 months | +16.07% | ||
| Current year | +4.85% |
| 1 week | 125.25 |  | 128.9 |
| 1 month | 119.85 | | 129.25 |
| Current year | 119.85 | | 131.65 |
| 1 year | 100.7 | | 142.45 |
| 3 years | 100.7 | | 186.4 |
| 5 years | 100.7 | | 231.5 |
| 10 years | 71.15 | | 231.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 2021-04-30 | |
| Director of Finance/CFO | 55 | 2023-06-30 | |
Laura Matz
CTO | Chief Tech/Sci/R&D Officer | - | 2021-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Christian Raabe
BRD | Director/Board Member | - | 2019-04-25 |
Jürgen Glaser
BRD | Director/Board Member | 63 | 2012-04-30 |
| Director/Board Member | 77 | 2014-05-08 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | 0.00% | 2.01% | 1 M€ | |
| +8.23% | 2.01% | 1 M€ | |
| -.--% | 1.8% | 962 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.22% | +2.55% | -5.58% | -29.93% | 65.31B | |
| -9.01% | -7.90% | +26.48% | +46.37% | 9.46B | |
| -0.15% | +3.07% | +30.05% | -10.01% | 8.87B | |
| -3.70% | -2.06% | -12.50% | +64.71% | 5.92B | |
| -0.55% | -0.37% | -12.19% | +121.83% | 5.59B | |
| -1.12% | +0.82% | +217.27% | +67.69% | 4.34B | |
| -2.42% | +0.35% | +430.29% | +931.23% | 3.05B | |
| -2.75% | -2.22% | +26.29% | +27.74% | 2.96B | |
| -2.59% | -2.98% | -8.46% | -22.27% | 2.79B | |
| -1.38% | -1.64% | +29.15% | +24.10% | 2.47B | |
| Average | -2.24% | -0.26% | +72.08% | +122.15% | 11.08B | |
| Weighted average by Cap. | -0.57% | +1.43% | +21.60% | +24.16% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 21.19B 25.04B 19.33B 18.48B 34.24B 2,271B 35.42B 225B 89.25B 1,096B 93.9B 91.97B 3,865B | 21.31B 25.18B 19.44B 18.59B 34.43B 2,284B 35.62B 227B 89.75B 1,102B 94.43B 92.48B 3,887B |
| Net income | 2.83B 3.34B 2.58B 2.47B 4.57B 303B 4.73B 30.06B 11.91B 146B 12.53B 12.27B 516B | 2.82B 3.34B 2.58B 2.46B 4.56B 303B 4.72B 30.03B 11.9B 146B 12.52B 12.26B 515B |
| Net Debt | 8.06B 9.53B 7.35B 7.03B 13.02B 864B 13.48B 85.71B 33.96B 417B 35.72B 34.99B 1,470B | 6.02B 7.11B 5.49B 5.25B 9.72B 645B 10.06B 63.99B 25.35B 311B 26.67B 26.12B 1,098B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-02-18 | 128.55 € | +1.22% | 173,415 |
| 26-02-17 | 127.00 € | +0.63% | 266,613 |
| 26-02-16 | 126.20 € | -1.25% | 142,446 |
| 26-02-13 | 127.80 € | +1.91% | 358,386 |
| 26-02-12 | 125.40 € | +0.04% | 257,242 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MRK Stock
Select your edition
All financial news and data tailored to specific country editions
